Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Executive Interview – Mutares

Executive Interview – Mutares

Mutares — 7 videos in collection

More on this equity

In the interview, Mark Friedrich (the company’s CFO) explains Mutares’s distinct investment approach focused on turnaround situations and the ‘buy and build’ strategy. Moreover, he discusses the current progress in the existing platform investments and most recent acquisitions. Mr. Friedrich also highlights that opening the London office to source deals in the UK and the Nordics has been a natural step after opening offices in Paris and Milan. Finally, he shares the company’s expectations with respect to future transactions.

< Previous
Next >

You may also be interested in these:

Growth Conf thumbnail (2)

Edison Growth Conference panel – 2024: The year of M&A?

Investment Companies

Vantage: Turnaround titan – learning about Mutares’s success and ambitions with CEO Robin Laik

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free